Netris Pharma logo

Netris Pharma

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$8.2M


Netris Pharma is a clinical-stage biopharmaceutical company focused on developing anti-cancer therapeutics, particularly its lead product NP137, which is designed to enhance the effectiveness of oncology treatments by overcoming drug resistance.

Total Funding

$24.4M

Headquarters

Lyon, France

Founded

N/A

Focus Areas

Biopharmaceutical
Anti-cancer Therapeutics
Clinical Trials
Oncology Treatments
Drug Development
Series A Funding

Investors

EIC Fund logo